First Time Loading...

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 109.48 USD 0.54%
Updated: Apr 16, 2024

Intrinsic Value

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. [ Read More ]

The intrinsic value of one ABT stock under the Base Case scenario is 98.35 USD. Compared to the current market price of 109.48 USD, Abbott Laboratories is Overvalued by 10%.

Key Points:
ABT Intrinsic Value
Base Case
98.35 USD
Overvaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Abbott Laboratories

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ABT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Abbott Laboratories

Provide an overview of the primary business activities
of Abbott Laboratories.

What unique competitive advantages
does Abbott Laboratories hold over its rivals?

What risks and challenges
does Abbott Laboratories face in the near future?

Has there been any significant insider trading activity
in Abbott Laboratories recently?

Summarize the latest earnings call
of Abbott Laboratories.

What significant events have occurred
in Abbott Laboratories over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Abbott Laboratories.

Provide P/S
for Abbott Laboratories.

Provide P/E
for Abbott Laboratories.

Provide P/OCF
for Abbott Laboratories.

Provide P/FCFE
for Abbott Laboratories.

Provide P/B
for Abbott Laboratories.

Provide EV/S
for Abbott Laboratories.

Provide EV/GP
for Abbott Laboratories.

Provide EV/EBITDA
for Abbott Laboratories.

Provide EV/EBIT
for Abbott Laboratories.

Provide EV/OCF
for Abbott Laboratories.

Provide EV/FCFF
for Abbott Laboratories.

Provide EV/IC
for Abbott Laboratories.

Show me price targets
for Abbott Laboratories made by professional analysts.

What are the Revenue projections
for Abbott Laboratories?

How accurate were the past Revenue estimates
for Abbott Laboratories?

What are the Net Income projections
for Abbott Laboratories?

How accurate were the past Net Income estimates
for Abbott Laboratories?

What are the EPS projections
for Abbott Laboratories?

How accurate were the past EPS estimates
for Abbott Laboratories?

What are the EBIT projections
for Abbott Laboratories?

How accurate were the past EBIT estimates
for Abbott Laboratories?

Compare the revenue forecasts
for Abbott Laboratories with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Abbott Laboratories and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Abbott Laboratories against its competitors.

Analyze the profit margins
(gross, operating, and net) of Abbott Laboratories compared to its peers.

Compare the P/E ratios
of Abbott Laboratories against its peers.

Discuss the investment returns and shareholder value creation
comparing Abbott Laboratories with its peers.

Analyze the financial leverage
of Abbott Laboratories compared to its main competitors.

Show all profitability ratios
for Abbott Laboratories.

Provide ROE
for Abbott Laboratories.

Provide ROA
for Abbott Laboratories.

Provide ROIC
for Abbott Laboratories.

Provide ROCE
for Abbott Laboratories.

Provide Gross Margin
for Abbott Laboratories.

Provide Operating Margin
for Abbott Laboratories.

Provide Net Margin
for Abbott Laboratories.

Provide FCF Margin
for Abbott Laboratories.

Show all solvency ratios
for Abbott Laboratories.

Provide D/E Ratio
for Abbott Laboratories.

Provide D/A Ratio
for Abbott Laboratories.

Provide Interest Coverage Ratio
for Abbott Laboratories.

Provide Altman Z-Score Ratio
for Abbott Laboratories.

Provide Quick Ratio
for Abbott Laboratories.

Provide Current Ratio
for Abbott Laboratories.

Provide Cash Ratio
for Abbott Laboratories.

What is the historical Revenue growth
over the last 5 years for Abbott Laboratories?

What is the historical Net Income growth
over the last 5 years for Abbott Laboratories?

What is the current Free Cash Flow
of Abbott Laboratories?

AI Assistant can make mistakes. Consider checking important information.
Financials

Balance Sheet Decomposition
Abbott Laboratories

Current Assets 22.7B
Cash & Short-Term Investments 7.3B
Receivables 6.6B
Other Current Assets 8.8B
Non-Current Assets 50.5B
Long-Term Investments 799m
PP&E 10.2B
Intangibles 32.5B
Other Non-Current Assets 7.1B
Current Liabilities 13.8B
Accounts Payable 4.3B
Accrued Liabilities 7B
Other Current Liabilities 2.5B
Non-Current Liabilities 20.8B
Long-Term Debt 13.6B
Other Non-Current Liabilities 7.2B
Efficiency

Earnings Waterfall
Abbott Laboratories

Revenue
40.1B USD
Cost of Revenue
-17.9B USD
Gross Profit
22.2B USD
Operating Expenses
-15.5B USD
Operating Income
6.7B USD
Other Expenses
-999m USD
Net Income
5.7B USD

Free Cash Flow Analysis
Abbott Laboratories

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ABT Profitability Score
Profitability Due Diligence

Abbott Laboratories's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Operating Income
60/100
Profitability
Score

Abbott Laboratories's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

ABT Solvency Score
Solvency Due Diligence

Abbott Laboratories's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
67/100
Solvency
Score

Abbott Laboratories's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABT Price Targets Summary
Abbott Laboratories

Wall Street analysts forecast ABT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABT is 128.26 USD with a low forecast of 108.07 USD and a high forecast of 148.05 USD.

Lowest
Price Target
108.07 USD
1% Downside
Average
Price Target
128.26 USD
17% Upside
Highest
Price Target
148.05 USD
35% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ABT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ABT Price
Abbott Laboratories

1M 1M
-3%
6M 6M
+19%
1Y 1Y
+5%
3Y 3Y
-9%
5Y 5Y
+53%
10Y 10Y
+239%
Annual Price Range
109.48
52w Low
90.19
52w High
120.96
Price Metrics
Average Annual Return 12.93%
Standard Deviation of Annual Returns 22.81%
Max Drawdown -35%
Shares Statistics
Market Capitalization 188.9B USD
Shares Outstanding 1 735 180 032
Percentage of Shares Shorted 0.84%

ABT Return Decomposition
Main factors of price return

What is price return decomposition?

ABT News

Other Videos

Last Important Events
Abbott Laboratories

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Abbott Laboratories

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Abbott Laboratories Logo
Abbott Laboratories

Country

United States of America

Industry

Health Care

Market Cap

188.9B USD

Dividend Yield

2.01%

Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 113,000 full-time employees. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Contact

ILLINOIS
ABBOTT PARK
100 Abbott Park Rd
+12246676100.0
https://www.abbott.com/

IPO

1937-03-01

Employees

113 000

Officers

Chairman of the Board, President & CEO
Mr. Robert B. Ford
CFO & Senior VP of Finance
Mr. Philip P. Boudreau
Executive VP, General Counsel & Secretary
Mr. Hubert L. Allen
Executive Vice President of Finance
Mr. Robert E. Funck Jr.
Executive VP and Group President of Established Pharmaceuticals & Nutritional Products
Mr. Daniel Gesua Sive Salvadori
Executive VP & Group President of Medical Devices
Ms. Lisa D. Earnhardt
Show More
Senior VP of Business & Technology Services and Chief Information Officer
Ms. Sabina Ewing
VP and Chief Ethics & Compliance Officer
Erica L. Battaglia
Vice President of Public Affairs & Corporate Marketing
Ms. Melissa Brotz
Senior Vice President of Commercial Operations, Marketing & Diabetes Care
Mr. Christopher J. Scoggins
Show Less

See Also

Discover More
What is the Intrinsic Value of one ABT stock?

The intrinsic value of one ABT stock under the Base Case scenario is 98.35 USD.

Is ABT stock undervalued or overvalued?

Compared to the current market price of 109.48 USD, Abbott Laboratories is Overvalued by 10%.